Tower Research Capital LLC (Trc) Blue Water Vaccines Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Blue Water Vaccines Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,777 shares of BWV stock, worth $2,172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,777
Previous 8,360
52.83%
Holding current value
$2,172
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BWV
# of Institutions
16Shares Held
2.82MCall Options Held
0Put Options Held
0-
American Financial Group Inc1.44MShares$244,9570.1% of portfolio
-
Cetera Investment Advisers Schaumburg, IL320KShares$54,4000.0% of portfolio
-
Zurcher Kantonalbank (Zurich Cantonalbank) Zurich, V8306KShares$52,0330.0% of portfolio
-
Bank Of America Corp Charlotte, NC125KShares$21,2720.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA114KShares$19,3250.0% of portfolio
About Blue Water Vaccines Inc.
- Ticker BWV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,744,900
- Market Cap $2.34M
- Description
- Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical de...